|
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury Clinical research trials and A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury. A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury clinical trial. Test subjects typically obtain the finest healthcare available for their A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury  A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
For Condition: Acute Lung Injury,Respiratory Distress Syndrome, Adult
Status: No longer recruiting
Sponsor(s): Eli Lilly and Company ,
Synopsis: The purpose of this study is to determine whether sivelestat will reduce the amount of time a patient must spend on a ventilator and/or increase the chance of survival of patients with acute lung injury.
Details: Acute lung injury often develops as a result of severe infection, sepsis, severe injuries, inhalation of foreign substances into the lungs, or pneumonia. The tissues and blood vessels in the lungs become inflammed, and the body does not receive enough oxygen. Patients with this condition are placed on a ventilator to assist with breathing. Patients entered into this study will be randomly assigned to one of two treatment groups: a sivelestat group or a placebo group. Once entered into the study, patients are monitored for up to 6 months.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - show evidence of acute lung injury - be on mechanical ventilation Exclusion Criteria - have undergone certain organ transplants - have severe underlying medical problems - be unlikely to survive - be pregnant or breast-feeding
Total Enrollment: 600
Location and Contact Information:
Additional Information:
Study ID Numbers: 6025;
Study Start Date: August 2001
Record last reviewed: September 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00036062
Other Respiratory Distress Syndrome, Adult Studies:
1. A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
Related Studies:
Other Respiratory Distress Syndrome, Adult Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects with Acute Lung Injury
|
|
|
|
|
|
|
|
